FDA Grants Orphan Drug Status to SAR446523 for Multiple Myeloma

The U.S. Food and Drug Administration (FDA) have made Orphan Drug Designation (ODD) of SAR446523, a GPRC5D monoclonal antibody, which is currently in development by Sanofi as a potential therapy for relapsed or refractory multiple myeloma...

Doctors Raise Alarm Over Rising Azoospermia Cases Effecting Male Infertility

Medical experts are sounding the alarm over a sharp increase in male infertility in India, now estimated to affect 27.5 million men and contribute to 40–50% of overall infertility cases. With the UNFPA 2025 State of World Population report...

HCGMCC's Prof. Dr. Raj Nagarkar Highlights Rising Burden of Lung Cancer

On the occasion of Lung Cancer Day, renowned oncosurgeon Prof Dr Raj Nagarkar, MD & Chief of Surgical Oncology and Robotic Services at HCG Manavata Cancer Centre, Nashik, has urged for urgent public attention to the rising incidence of lung cancer...

Maxivision Launches 10 Super Speciality Eye Centres in Chennai

Maxivision Super Speciality Eye Hospitals (‘Maxivision’), one of India's fastest-growing eye care providers, announced its strategic expansion in Chennai with the launch of 10 eye hospitals/vision centres across Chennai...

Why Pharma Firms Are Upgrading to Modern ERP Systems

In an industry where anything that goes wrong in terms of compliance could lead to either recalls, regulatory fines, or harm to patients, the pharmaceutical sector is now under grave pressure to go digital...

Iberia Pharmaceuticals Expands with Rs 70 Cr Skincare Facility in Jhajjar

Iberia Pharmaceuticals is establishing a modern skincare manufacturing and research plant in Jhajjar Haryana, a significant first step to enhance its presence in India in the skincare sector. The modern unit will include 60,000 sq. ft. and...

Revna and AstraZeneca Elevate Lung Cancer Care in Ghana

In a momentous advancement for lung cancer care in Ghana, AstraZeneca and Revna Biosciences have renewed their commitment to improve access to diagnosis and treatment. Building on a strategic initiative announced in April 2025, this undertaking...

Apollo Cancer Centres Launches Early Screening and Diagnosis Program

Reinforcing its commitment to preventive oncology for women, Apollo Cancer Centres (ACCs) today launched End-O Check, a comprehensive early detection program targeting women aged 45 and above...

Everest Group Recognizes Indegene as a Leader in Life Sciences AI and Analytics

Everest Group, a leading global research and consulting firm, named Indegene a Leader in Life Sciences AI and Analytics Services for Commercial PEAK Matrix Assessment 2025. Everest Group acknowledged Indegene’s wide-ranging AI and Analytics...

Medtech Industry Flags Overpriced Imported Medical Devices

In an increasing threat to India’s medtech industry, imported medical devices are now facing pressure of being sold at inflated high Maximum Retail Prices (MRPs) or without adequately disclosed prices. Indigenous manufacturers of medical devices...

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.